August 09, 2018
The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 7 August 2018, it purchased 1,400,000 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") at 3.50p per Ordinary Share (the "Purchase"). Following the purchase, Vulpes has a total direct and indirect interest in 57,759,431 equivalent to 19.6% of Proteome Sciences' total issued share capital